| CD3D; CD3d molecule, delta (CD3-TCR complex) [KO: K06450] |
| CD3E; CD3e molecule, epsilon (CD3-TCR complex) [KO: K06451] |
| CD3G; CD3g molecule, gamma (CD3-TCR complex) [KO: K06452] |
| CD247; CD247 molecule [KO: K06453] |
| |
| CD8A; CD8a molecule [KO: K06458] |
| CD8B; CD8b molecule [KO: K06459] |
| PTPRC; protein tyrosine phosphatase, receptor type, C [KO: K06478] [EC: 3.1.3.48] |
| LCK; lymphocyte-specific protein tyrosine kinase [KO: K05856] [EC: 2.7.10.2] |
| |
| ZAP70; zeta-chain (TCR) associated protein kinase 70kDa [KO: K07360] [EC: 2.7.10.2] |
| LCP2; lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) [KO: K07361] |
| LAT; linker for activation of T cells [KO: K07362] |
| |
| |
| NCK1; NCK adaptor protein 1 [KO: K07365] |
| NCK2; NCK adaptor protein 2 [KO: K07365] |
| VAV3; vav 3 guanine nucleotide exchange factor [KO: K05730] |
| VAV1; vav 1 guanine nucleotide exchange factor [KO: K05730] |
| VAV2; vav 2 guanine nucleotide exchange factor [KO: K05730] |
| GRAP2; GRB2-related adaptor protein 2 [KO: K07366] |
| GRB2; growth factor receptor-bound protein 2 [KO: K04364] |
| PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 [KO: K04409] [EC: 2.7.11.1] |
| PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 [KO: K04410] [EC: 2.7.11.1] |
| PAK3; p21 protein (Cdc42/Rac)-activated kinase 3 [KO: K05733] [EC: 2.7.11.1] |
| PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 [KO: K05734] [EC: 2.7.11.1] |
| PAK6; p21 protein (Cdc42/Rac)-activated kinase 6 [KO: K05735] [EC: 2.7.11.1] |
| PAK7; p21 protein (Cdc42/Rac)-activated kinase 7 [KO: K05736] [EC: 2.7.11.1] |
| RHOA; ras homolog family member A [KO: K04513] |
| CDC42; cell division cycle 42 [KO: K04393] |
| DLG1; discs, large homolog 1 (Drosophila) [KO: K12076] |
| |
| |
| |
| |
| |
| PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme [KO: K04348] [EC: 3.1.3.16] |
| PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme [KO: K04348] [EC: 3.1.3.16] |
| PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme [KO: K04348] [EC: 3.1.3.16] |
| PPP3R1; protein phosphatase 3, regulatory subunit B, alpha [KO: K06268] |
| PPP3R2; protein phosphatase 3, regulatory subunit B, beta [KO: K06268] |
| CHP1; calcineurin-like EF-hand protein 1 [KO: K06268] |
| CHP2; calcineurin-like EF-hand protein 2 [KO: K06268] |
| NFATC4; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 [KO: K04446] |
| NFATC1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 [KO: K04446] |
| NFAT5; nuclear factor of activated T-cells 5, tonicity-responsive [KO: K04446] |
| NFATC2; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 [KO: K04446] |
| NFATC3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 [KO: K04446] |
| SOS1; son of sevenless homolog 1 (Drosophila) [KO: K03099] |
| SOS2; son of sevenless homolog 2 (Drosophila) [KO: K03099] |
| RASGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated) [KO: K04350] |
| HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog [KO: K02833] |
| KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog [KO: K07827] |
| NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO: K07828] |
| RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 [KO: K04366] [EC: 2.7.11.1] |
| MAP2K1; mitogen-activated protein kinase kinase 1 [KO: K04368] [EC: 2.7.12.2] |
| MAP2K2; mitogen-activated protein kinase kinase 2 [KO: K04369] [EC: 2.7.12.2] |
| |
| |
| FOS; FBJ murine osteosarcoma viral oncogene homolog [KO: K04379] |
| JUN; jun proto-oncogene [KO: K04448] |
| CARD11; caspase recruitment domain family, member 11 [KO: K07367] |
| BCL10; B-cell CLL/lymphoma 10 [KO: K07368] |
| MALT1; mucosa associated lymphoid tissue lymphoma translocation gene 1 [KO: K07369] [EC:3.4.22.-] |
| MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO: K04427] [EC: 2.7.11.25] |
| MAP2K7; mitogen-activated protein kinase kinase 7 [KO: K04431] [EC: 2.7.12.2] |
| CHUK; conserved helix-loop-helix ubiquitous kinase [KO: K04467] [EC: 2.7.11.10] |
| IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO: K07209] [EC: 2.7.11.10] |
| IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma [KO: K07210] |
| NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO: K02580] |
| RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian) [KO: K04735] |
| NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [KO: K04734] |
| NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta [KO: K02581] |
| NFKBIE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon [KO: K05872] |
| CD28; CD28 molecule [KO: K06470] |
| ICOS; inducible T-cell co-stimulator [KO: K06713] |
| CD40LG; CD40 ligand [KO: K03161] |
| PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha) [KO: K02649] |
| PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5 [KO: K02649] |
| PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta) [KO: K02649] |
| PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma) [KO: K02649] |
| PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha [KO: K00922] [EC: 2.7.1.153] |
| PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta [KO: K00922] [EC: 2.7.1.153] |
| PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta [KO: K00922] [EC: 2.7.1.153] |
| PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma [KO: K00922] [EC: 2.7.1.153] |
| PDK1; pyruvate dehydrogenase kinase, isozyme 1 [KO: K12077] [EC: 2.7.11.2] |
| AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO: K04456] [EC: 2.7.11.1] |
| AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO: K04456] [EC: 2.7.11.1] |
| AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) [KO: K04456] [EC: 2.7.11.1] |
| MAP3K8; mitogen-activated protein kinase kinase kinase 8 [KO: K04415] [EC: 2.7.11.25] |
| MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO: K04466] [EC: 2.7.11.25] |
| |
| PDCD1; programmed cell death 1 [KO: K06744] |
| CTLA4; cytotoxic T-lymphocyte-associated protein 4 [KO: K06538] |
| PTPN6; protein tyrosine phosphatase, non-receptor type 6 [KO: K05697] [EC: 3.1.3.48] |
| CBLC; Cbl proto-oncogene, E3 ubiquitin protein ligase C [KO: K04707] [EC: 6.3.2.19] |
| CBL; Cbl proto-oncogene, E3 ubiquitin protein ligase [KO: K04707] [EC: 6.3.2.19] |
| CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B [KO: K04707] [EC: 6.3.2.19] |
| IL2; interleukin 2 [KO: K05429] |
| IL4; interleukin 4 [KO: K05430] |
| IL5; interleukin 5 (colony-stimulating factor, eosinophil) [KO: K05428] |
| IL10; interleukin 10 [KO: K05443] |
| IFNG; interferon, gamma [KO: K04687] |
| CSF2; colony stimulating factor 2 (granulocyte-macrophage) [KO: K05427] |
| TNF; tumor necrosis factor [KO: K03156] |
| |
| |
| |